Abstract
This study aims to investigate the impact of intangible assets internally generated (development costs, and patents) in the market value of pharmaceutical companies in Jordan. The study population of financial employees (Auditors, analysts, accountants) working in six Jordanian pharmaceutical companies, the sample was chosen randomly consisted of 62 financials. The study data were collected through the development of a questionnaire. The results showed that investment in intangible assets strongly affect maximize the market value of Jordanian pharmaceutical companies .It has also shown to maintain the confidentiality of information of manufacturing of patents to conserve the competitive position of the pharmaceutical companies for a long time. The study supports the success of the Jordanian pharmaceutical companies to maximize their competitiveness through development costs and patents.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
